GSK will be the marketing authorisation holder for the next generation vaccine, except in Switzerland, and will have exclusive rights to develop, manufacture, and market the next generation COVID ...

according to the Swiss Federal Statistical Office. The index reading topped analyst forecasts of -38, according to Bloomberg. And in corporate news, GSK said Monday that it has agreed to acquire ...

The WSJ report said the U.S. Attorney's Office for the Southern District of New York, which includes Manhattan, is taking a closer look at GSK's claims. "We cannot comment because we have not ...